Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Swi/Snf Complex, Promising Target in Melanoma Therapy: Snapshot View Publisher



Mollapour Sisakht M1, 2 ; Amirkhani MA3 ; Nilforoushzadeh MA3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Biotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biochemistry, Erasmus University Medical Center, Rotterdam, Netherlands
  3. 3. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Frontiers in Medicine Published:2023


Abstract

Therapeutic strategies based on epigenetic regulators are rapidly increasing in light of recent advances in discovering the role of epigenetic factors in response and sensitivity to therapy. Although loss-of-function mutations in genes encoding the SWItch/Sucrose NonFermentable (SWI/SNF) subunits play an important role in the occurrence of ~34% of melanomas, the potential of using inhibitors and synthetic lethality interactions between key subunits of the complex that play an important role in melanoma progression must be considered. Here, we discuss the importance of the clinical application of SWI/SNF subunits as a promising potential therapeutic in melanoma. Copyright © 2023 Mollapour Sisakht, Amirkhani and Nilforoushzadeh.
Related Docs
Experts (# of related papers)